The website says that if you can't find a convenient location, you should check back later or contact your local health department or health care provider. has a search filter for the "newly authorized bivalent" booster options, which you can use to find other locations near you.Check your state's health department website to see if it's offering similar resources. Multiple states - including Massachusetts, New Jersey and Colorado - have websites to help you find other clinics with new boosters in stock.You can view and schedule appointments on the Albertsons website or app. The company's brands offering the boosters include Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, Acme, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market, Haggen, Carrs, Amigos and Market Street. Albertsons, one of North America's largest grocery chains, started offering Pfizer and Moderna's updated boosters at some of its locations on Monday - along with a coupon for 10% off your next grocery purchase if you get the shot.You can schedule an appointment on the Rite Aid website or the Bartell Drugs website. Rite Aid, which also owns Pacific Northwest chain Bartell Drugs, began offering both Pfizer and Moderna's new boosters last week at some of its store locations.You can schedule those appointments on the CVS website or on the pharmacy's app. Its online system allows you to schedule multiple patients at once, which could make it easier for your family to get vaccinated together. CVS is also offering both updated boosters.You can view and schedule appointments on the Walgreens website, on the pharmacy's app or by calling 1-800-WALGREENS. The shots haven't reached all of the chain's locations yet, but new appointments are being added daily. Walgreens is offering both Pfizer and Moderna's new boosters.Here's where you can get them if you're eligible: The new shots are free of charge to receive, for now. The agency's advisors also say that if you've recently had Covid, you should consider waiting three months after testing negative before getting your updated booster. That could also affect demand.To be eligible, you'll need to have completed your primary vaccination series - and be at least two months out from your last dose of any Covid vaccine, according to the CDC. William Schaffner, an infectious diseases specialist at Vanderbilt University and a liaison to the CDC's Advisory Committee on Immunization practices, said it is possible that the ACIP could make a weaker recommendation for younger, healthier people. Some doctors suggest that annual shots should be targeted at the elderly and other high risk people, who are most likely to have dire outcomes if they catch COVID-19.ĭr. The shots are aimed at XBB.1.5, a subvariant that is similar to EG.5 and also a sub-lineage of the still dominant Omicron variant.ĬOVID-19 related hospitalizations are up more than 40% off of recent lows hit in June, but are still more than 90% below peak levels hit during the January 2022 Omicron outbreak, according to CDC data. She suggested Americans should view these shots as an annual measure to protect oneself, in line with the annual flu shot.Īs with the flu, Pfizer PFE.N/BioNTech SE 22UAy.DE, Moderna MRNA.O and Novavax NVAX.O, have created versions of the COVID vaccine to try to match the variant they believe will be circulating this fall. Food and Drug Administration and recommended by the CDC - to be rolled out in the third or fourth week of September. ĬDC Director Mandy Cohen said last week in a podcast that she expects the shots - which still need to be authorized by the U.S. Centers for Disease Control and Prevention (CDC). Over 1.1 million people in the United States have died from COVID, according to the U.S. The COVID public health emergency ended in May and the government has handed much of the duty of vaccinating America to the private sector. It was 50 million in the US, and it seems likely to be lower than that, given that there's less concern about COVID this year than last year," Yee said. "Take a look at what happened last winter. Jefferies analyst Michael Yee said he does not expect the autumn campaign to reach last year's. Last year, Pfizer and Moderna's vaccine sales topped $56 billion worldwide analysts project around $20 billion for this year. Its biggest rival, Moderna, conceded demand could be as few as 50 million shots. COVID-19 vaccine makers have pared back expectations for this fall's vaccination campaign, with Pfizer – the largest maker of mRNA shots with BioNTech – recently warning that it might need to cut jobs if it does not do well.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |